CAS RN: 215874-86-5
3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine
Product Availability
Choose a grade to view its available package options.
2 package records2 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250523 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251014 |
50mg |
In stock |
Shanghai, Shandong | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 1g, 0.1g, 0.25g
- Available purity: >97%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 215874-86-5
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 1g |
>97% |
4
In Stock
|
Shanghai |
Inquiry |
| 0.1g |
>97% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>97% |
2
In Stock
|
Beijing |
Inquiry |
215874-86-5 / 5-methyl-3-[6-[(1-methyltriazol-4-yl)methoxy]-[1,2,4]triazolo[3,4-a]phthalazin-3-yl]-1,2-oxazole
Standard CAS: 215874-86-5
Multi CAS: No
Basic Information
CAS
215874-86-5
Multi CAS
No
Molecular Formula
C17H14N8O2
Molecular Weight
362.300000
Exact Mass
362.123972
SMILES
CC1=CC(=NO1)C2=NN=C3N2N=C(C4=CC=CC=C43)OCC5=CN(N=N5)C
InChI
InChI=1S/C17H14N8O2/c1-10-7-14(22-27-10)16-20-19-15-12-5-3-4-6-13(12)17(21-25(15)16)26-9-11-8-24(2)23-18-11/h3-8H,9H2,1-2H3
InChIKey
NZMJFRXKGUCYNP-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
27
Aromatic heavy atom count
23
Fraction Csp3
0.18
Rotatable bonds
4
H-bond acceptors
10
Molar refractivity
93.86
TPSA
109.05
LogP / Solubility
WLOGP
1.95
MLOGP
1.73
XLogP3
1.1
Consensus LogP
1.59
Log S (ESOL)
-3.68
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.94
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-4.11
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.55
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3.5